{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T04:17:13Z","timestamp":1765772233608},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.transproceed.2006.08.066","type":"journal-article","created":{"date-parts":[[2006,11,10]],"date-time":"2006-11-10T12:27:55Z","timestamp":1163161675000},"page":"2419-2423","source":"Crossref","is-referenced-by-count":21,"title":["Efficacy and Safety of Valsartan, an Angiotensin II Receptor Antagonist, in Hypertension After Renal Transplantation: A Randomized Multicenter Study"],"prefix":"10.1016","volume":"38","author":[{"given":"A.","family":"Andr\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2006.08.066_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ndt\/10.supp1.95","article-title":"Hypertension and ischaemic heart disease in renal transplant recipients","volume":"10","author":"Raine","year":"1995","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.transproceed.2006.08.066_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0272-6386(93)70098-J","article-title":"Hypertension after renal transplantation","volume":"21","author":"Ponticelli","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 8","key":"10.1016\/j.transproceed.2006.08.066_bib3","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1681\/ASN.V48s30","article-title":"Hypertension after renal transplantation","volume":"4","author":"First","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2006.08.066_bib4","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1681\/ASN.V22s37","article-title":"Pathophysiology and treatment of post-transplant hypertension","volume":"2","author":"Luke","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2006.08.066_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0041-1345(96)00066-8","article-title":"Hypertension in patients after renal transplantatio","volume":"29","author":"Budde","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.08.066_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0041-1345(98)00043-8","article-title":"Incidence of post-transplant hypertension among renal allograft recipients","volume":"30","author":"Malek-Hosseini","year":"1998","journal-title":"Transplant Proc"},{"issue":"Suppl 6","key":"10.1016\/j.transproceed.2006.08.066_bib7","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00007890-200109271-00004","article-title":"Mechanisms and consequences of arterial hypertension after renal transplantation","volume":"72","author":"Koomans","year":"2001","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2006.08.066_bib8","first-page":"6","article-title":"Report on the management al renal failure in Europe XXIII","volume":"9","author":"Geerlings","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.066_bib9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ndt\/14.3.648","article-title":"Cardiovascular morbidity and risk factors in renal transplant patients","volume":"14","author":"Aakhus","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.066_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0272-6386(00)70302-7","article-title":"ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy","volume":"35","author":"Stigant","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2006.08.066_bib11","first-page":"170","article-title":"Cardiovascular disease after renal transplantation","volume":"20","author":"Kasiske","year":"2000","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.transproceed.2006.08.066_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","article-title":"Association of chronic Kidney graf failure with recipient blood pressure","volume":"53","author":"Opelz","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2006.08.066_bib13","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1046\/j.1523-1755.1999.00752.x","article-title":"Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology","volume":"56","author":"Cosio","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2006.08.066_bib14","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1046\/j.1523-1755.2001.0590031158.x","article-title":"Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients","volume":"59","author":"Cosio","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2006.08.066_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0149-2918(96)80040-3","article-title":"The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension","volume":"18","author":"Oparil","year":"1996","journal-title":"Clin Therap"},{"key":"10.1016\/j.transproceed.2006.08.066_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/j.1552-4604.1997.tb04767.x","article-title":"Valsartan a new Angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydroclorotiazide","volume":"37","author":"Benz","year":"1997","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2006.08.066_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/ndt\/16.suppl_1.117","article-title":"Angiotensin II type 1 (AT1) receptor antagonist in the treatment of hypertension after renal transplantation","volume":"16","author":"Holgado","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.066_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1523-1755.1998.06827.x","article-title":"Efficacy and Safety of Losartan in the treatment of hypertension in renal transplant recipients","volume":"68","author":"Del Castillo","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2006.08.066_bib19","first-page":"572","article-title":"Effect of the calcium channel blocker diltiazen on cyclosporine A blood levels and dose requirements","volume":"20","author":"Kohlhaw","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.08.066_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM198302173080706","article-title":"Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis in a solitary kidney","volume":"308","author":"Hricik","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2006.08.066_bib21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet"},{"issue":"Suppl 8","key":"10.1016\/j.transproceed.2006.08.066_bib22","first-page":"523","article-title":"Chronic rejection","volume":"4","author":"Matas","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2006.08.066_bib23","first-page":"126","article-title":"Chronic allograft dysfunction; mechanisms and new approaches to therapy","volume":"20","author":"Womer","year":"2000","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.transproceed.2006.08.066_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2006.08.066_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-127-5-199709010-00001","article-title":"Effect of angiotensin-converting enzyme inhibitors on the progression of non-diabetic renal disease: a meta-analysis of randomised trials","volume":"127","author":"Giatras","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2006.08.066_bib26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and Nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2006.08.066_bib27","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of Irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2006.08.066_bib28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1523-1755.1999.00597.x","article-title":"Losartan decreases plasma levels of TGF-\u25a1 in transplant patients with chronic allograft nephropathy","volume":"56","author":"Campistol","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2006.08.066_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0272-6386(00)70302-7","article-title":"ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy","volume":"35","author":"Stigant","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2006.08.066_bib30","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.transproceed.2005.01.043","article-title":"Renoprotective effect of early inhibition of the renin\u2013angiotensin system in renal transplant recipients","volume":"37","author":"Montanaro","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.08.066_bib31","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfh462","article-title":"Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy","volume":"19","author":"Artz","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.066_bib32","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.transproceed.2003.08.012","article-title":"Renin-angiotensin system blockade in biopsy-proven allograft nephropathy","volume":"35","author":"Zaltzman","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.08.066_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1399-0012.2005.00366.x","article-title":"Chronic allograft nephropathy and nephrotic range proteinuria","volume":"19","author":"Ramanathan","year":"2005","journal-title":"Clin Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506009638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506009638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T17:05:19Z","timestamp":1628096719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134506009638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0041134506009638"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2006.08.066","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}